- Open Access
Unicystic ameloblastoma of the mandible - an unusual case report and review of literature
© Ramesh et al; licensee BioMed Central Ltd. 2010
Received: 1 November 2009
Accepted: 14 January 2010
Published: 14 January 2010
Ameloblastoma is a true neoplasm of odontogenic epithelial origin. It is the second most common odontogenic neoplasm, and only odontoma outnumbers it in reported frequency of occurrence. Its incidence, combined with its clinical behavior, makes ameloblastoma the most significant odontogenic neoplasm. Unicystic ameloblastoma (UA) refers to those cystic lesions that show clinical, radiographic, or gross features of a mandibular cyst, but on histologic examination show a typical ameloblastomatous epithelium lining part of the cyst cavity, with or without luminal and/or mural tumor growth. It accounts for 5-15% of all intraosseous ameloblastomas. We report a case of unicystic ameloblastoma in a 30-year-old female, and review the literature.
Many benign lesions cause mandibular swellings, and these can be divided into those of odontogenic and nonodontogenic origin. Lesions include ameloblastoma, radicular cyst, dentigerous cyst, keratocystic odontogenic tumour, central giant cell granuloma, fibro-osseous lesions and osteomas . The most common tumour of odontogenic origin is ameloblastoma, which develops from epithelial cellular elements and dental tissues in their various phases of development. It is a slow-growing, persistent, and locally aggressive neoplasm of epithelial origin. Its peak incidence is in the 3rd to 4th decades of life and has an equal sex distribution. It is often associated with an unerupted third molar . It may be detected during the course of routine radiography.
The vast majority of ameloblastomas arise in the mandible, and the majority of these are found in the angle and ramus region. There are three forms of ameloblastomas, namely multicystic, peripheral, and unicystic tumors . Multicystic ameloblastoma is the most common variety and represents 86% of cases. Peripheral tumors are odontogenic tumors, with the histological characteristics of intraosseous ameloblastoma that occur solely in the soft tissues covering the tooth-bearing parts of the jaws. Unicystic tumors include those that have been variously referred to as mural ameloblastomas, luminal ameloblastomas, and ameloblastomas arising in dentigerous cysts . The goal of treatment ameloblastoma is to achieve complete excision and appropriate reconstruction. We present a case of a large unicystic mandibular ameloblastoma in a 30 year old female.
Unilocular ameloblastoma (UA) is a rare type of ameloblastoma, accounting for about 6% of ameloblastomas. It usually occurs in a younger age group, with about 50% of the cases occurring in the second decade of life. More than 90% are located in the mandible [5–7]. Between 50 and 80% of cases are associated with tooth impaction, the mandibular third molar being most often involved. The 'dentigerous' type occurs 8 years earlier on average than the 'non-dentigerous' variant. Patients most commonly present with swelling and facial asymmetry, pain being an occasional presenting symptom. Mucosal ulceration is rare, but may be caused by continued growth of the tumor. Small lesions are sometimes discovered more on routine radiographic screening examinations or as a result of local effects (like tooth mobility, occlusal alterations and failure of eruption of teeth) produced by the tumor . Histologically, the minimum criterion for diagnosing a lesion as UA is the demonstration of a single cystic sac lined by odontogenic (ameloblastomatous) epithelium often seen only in focal areas. UA should be differentiated from odontogenic cysts because the former has a higher rate of recurrence than the latter . In a clinicopathologic study of 57 cases of unicystic ameloblastoma, Ackermann  classified this entity into the following three histologic groups:
Group I: Luminal UA (tumor confined to the luminal surface of the cyst)
Group II: Intraluminal/plexiform UA (nodular proliferation into the lumen without infiltration of tumor cells into the connective tissue wall), and
Group III: Mural UA (invasive islands of ameloblastomatous epithelium in the connective tissue wall not involving the entire epithelium).
Another histologic subgrouping by Philipsen and Reichart  has also been described:
Subgroup 1: Luminal UA
Subgroup 1.2: Luminal and intraluminal
Subgroup 1.2.3: Luminal, intraluminal and intramural
Subgroup 1.3: Luminal and intramural
The UAs diagnosed as subgroups 1 and 1.2 can be treated conservatively (careful enucleation), whereas subgroups 1.2.3 and 1.3 showing intramural growths require treated radical resection, as for a solid or multicystic ameloblastoma . Following enucleation, vigorous curettage of the bone should be avoided as it may implant foci of ameloblastoma more deeply into bone. Chemical cauterization with Carnoy's solution is also advocated for subgroups 1 and 1.2. Subgroups 1.2.3 and 1.3 have a high risk for recurrence, requiring more aggressive surgical procedures. This is because the cystic wall in these cases has islands of ameloblastoma tumor cells and there may be penetration into the surrounding cancellous bone [10–12]. Late recurrence following treatment is commonly seen, the average interval for recurrence being 7 years. Recurrence is also related to histologic subtypes of UA, with those invading the fibrous wall having a rate of 35.7%, but others only 6.7% . Recurrence rates are also related to the type of initial treatment. Lau et al  reported recurrence rates of 3.6% for resection, 30.5% for enucleation alone, 16% for enucleation followed by Carnoy's solution application, and 18% by marsupialization followed by enucleation (where the lesion reduced in size).
Conflict of interests
The authors declare that they have no competing interests.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
The authors are grateful to Dr. Arun Shet for review of the manuscript.
- Kahairi A, Ahmad RL, Wan Islah L, Norra H: Management of large mandibular ameloblastoma - a case report and literature reviews. Archives of Orofacial Sciences. 2008, 3 (2): 52-55.Google Scholar
- Gerzenshtein J, Zhang F, Caplan J, Anand V, Lineaweaver W: Immediate mandibular reconstruction with microsurgical fibula flap transfer following wide resection for ameloblastoma. J Craniofac Surg. 2006, 17 (1): 178-182. 10.1097/01.scs.0000190350.37978.2c.View ArticlePubMedGoogle Scholar
- Philipsen HP, Reichart PA: Classification of odontogenic tumors and allied lesions. Odontogenic tumors and allied lesions. 2004, Quintessence Pub. Co. Ltd, 21-3.Google Scholar
- Chana , Jagdeep S, Yang-Ming Chang, Wei , Fu-Chan , Shen , Yu-Fen , Chan Chiu-Po, Lin Hsiu-Na, Tsai Chi-Ying, Jeng Seng-Feng: Segmental mandibulectomy and immediate free fibula osteoseptocutaneous flap reconstruction with endosteal implants: An ideal treatment method for mandibular ameloblastoma. Plast Reconstr Surg. 2004, 113 (1): 80-87. 10.1097/01.PRS.0000097719.69616.29.View ArticlePubMedGoogle Scholar
- Philipsen HP, Reichart PA: Unicystic ameloblastoma. Odontogenic tumors and allied lesions. 2004, London: Quintessence Pub. Co. Ltd, 77-86.Google Scholar
- Pizer ME, Page DG, Svirsky JA: Thirteen-year follow-up of large recurrent unicystic ameloblastoma of the mandible in a 15-year-old boy. J Oral Maxillofac Surg. 2002, 60: 211-5. 10.1053/joms.2002.29828.View ArticlePubMedGoogle Scholar
- Navarro CM, Principi SM, Massucato EM, Sposto MR: Maxillary unicystic ameloblastoma. Dentomaxillofac Radiol. 2004, 33: 60-2. 10.1259/dmfr/32974609.View ArticlePubMedGoogle Scholar
- Roos RE, Raubenheimer EJ, van Heerden WF: Clinico-pathological study of 30 unicystic ameloblastomas. J Dent Assoc S Afr. 1994, 49: 559-62.PubMedGoogle Scholar
- Konouchi H, Asaumi J, Yanagi Y, Hisatomi M, Kawai N, Matsuzaki H, Kishi K: Usefulness of contrast enhanced-MRI in the diagnosis of unicystic ameloblastoma. Oral Oncol. 2006, 42: 481-6. 10.1016/j.oraloncology.2005.10.001.View ArticlePubMedGoogle Scholar
- Li TJ, Kitano M, Arimura K, Sugihara K: Recurrence of unicystic ameloblastoma: A case report and review of the literature. Arch Pathol Lab Med. 1998, 122: 371-4.PubMedGoogle Scholar
- Li TJ, Browne RM, Matthews JB: Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology. 1995, 26: 219-28. 10.1111/j.1365-2559.1995.tb01435.x.View ArticlePubMedGoogle Scholar
- Li T, Wu Y, Yu S, Yu G: Clinicopathological features of unicystic ameloblastoma with special reference to its recurrence. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002, 37: 210-2.PubMedGoogle Scholar
- Lau SL, Samman N: Recurrence related to treatment modalities of unicystic ameloblastoma: A systematic review. Int J Oral Maxillofac Surg. 2006, 35: 681-90. 10.1016/j.ijom.2006.02.016.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.